reports consultant honorary from Akero, Alentis, Alexion, Altimmune, Astra Zeneca, 89Bio, Boehringer Ingelheim, Boston Pharmaceuticals, Gilead Sciences, GSK, Ipsen, Inventiva Pharma, Madrigal Pharmaceuticals, Krya Therapeutics, Eli Lilly, eTherapeutics, Merck, MSD Sharp & Dohme GmbH, Novo Nordisk and Roche
Supports gut health, aids tissue repair, helps manage inflammation, and benefits various other body systems
Wall Street analysts predict that GLP-1 drugsboth injectable and oralwill generate annual sales exceeding $100 billion by 2030
Despite being one of the more affordable options on the market, it's third-party tested for purity and potency and free from artificial additives and preservatives
The article covers the science behind appetite control and metabolic support, helping you understand how natural ingredients work synergistically to promote satiety and blood sugar balance
doi:10.2337/diabetes.51.3.652 22